2329 Stock Overview
An investment holding company, develops and operates of real estate properties in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Glory Health Industry Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.096 |
| 52 Week High | HK$0.25 |
| 52 Week Low | HK$0.021 |
| Beta | -0.018 |
| 1 Month Change | -29.93% |
| 3 Month Change | -21.95% |
| 1 Year Change | 284.00% |
| 3 Year Change | -68.52% |
| 5 Year Change | -94.11% |
| Change since IPO | -96.16% |
Recent News & Updates
Recent updates
We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed
Jun 21
Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?
Oct 07Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?
Jun 21A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)
May 13Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?
Oct 04We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt
Apr 20Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load
Sep 02We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package
Jun 23Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet
May 13Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.
Jan 31Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?
Jan 10
What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?
Dec 20Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet
Dec 03Shareholder Returns
| 2329 | HK Real Estate | HK Market | |
|---|---|---|---|
| 7D | 3.2% | 0.04% | 1.5% |
| 1Y | 284.0% | -8.6% | 20.6% |
Return vs Industry: 2329 exceeded the Hong Kong Real Estate industry which returned -8.6% over the past year.
Return vs Market: 2329 exceeded the Hong Kong Market which returned 20.6% over the past year.
Price Volatility
| 2329 volatility | |
|---|---|
| 2329 Average Weekly Movement | 13.1% |
| Real Estate Industry Average Movement | 9.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.0% |
Stable Share Price: 2329 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2329's weekly volatility has decreased from 27% to 13% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 552 | Zhangsun Zhang | www.glorypty.com |
Glory Health Industry Limited, an investment holding company, develops and operates of real estate properties in the People’s Republic of China. The company operates through four segments: Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties.
Glory Health Industry Limited Fundamentals Summary
| 2329 fundamental statistics | |
|---|---|
| Market cap | HK$426.66m |
| Earnings (TTM) | -HK$378.63m |
| Revenue (TTM) | HK$2.17b |
0.2x
P/S Ratio-1.1x
P/E RatioIs 2329 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2329 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.84b |
| Gross Profit | CN¥201.85m |
| Other Expenses | CN¥557.60m |
| Earnings | -CN¥355.76m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.08 |
| Gross Margin | 9.91% |
| Net Profit Margin | -17.47% |
| Debt/Equity Ratio | 161.3% |
How did 2329 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 14:40 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Glory Health Industry Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|